Ashwell J D, DeFranco A L, Paul W E, Schwartz R H
J Exp Med. 1984 Mar 1;159(3):881-905. doi: 10.1084/jem.159.3.881.
In this report we have examined the ability of small resting B cells to act as antigen-presenting cells (APC) to antigen-specific MHC-restricted T cells as assessed by either T cell proliferation or T cell-dependent B cell stimulation. We found that 10 of 14 in vitro antigen-specific MHC-restricted T cell clones and lines and three of four T cell hybridomas could be induced to either proliferate or secrete IL-2 in the presence of lightly irradiated (1,000 rads) purified B cells and the appropriate foreign antigen. All T cell lines and hybridomas were stimulated to proliferate or make IL-2 by macrophage- and dendritic cell-enriched populations and all T cells tested except one hybridoma caused B cell activation when stimulated with B cells as APC. Furthermore, lightly irradiated, highly purified syngeneic B cells were as potent a source of APC for inducing B cell activation as were low density dendritic and macrophage-enriched cells. Lymph node T cells freshly taken from antigen-primed animals were also found to proliferate when cultured with purified B cells and the appropriate antigen. Thus, small resting B cells can function as APC to a variety of T cells. This APC function was easily measured when the cells were irradiated with 1,000 rads, but was greatly diminished or absent when they were irradiated with 3,300 rads. Thus, the failure of some other laboratories to observe this phenomenon may be the result of the relative radiosensitivity of the antigen-presenting function of the B cells. In addition, this radiosensitivity allowed us to easily distinguish B cell antigen presentation from presentation by the dendritic cell and macrophage, as the latter was resistant to 3,300 rads. Finally, one T cell clone that failed to proliferate when B cells were used as APC was able to recruit allogeneic B cells to proliferate in the presence of syngeneic B cells and the appropriate antigen. This result suggests that there are at least two distinct pathways of activation in T cells, one that leads to T cell proliferation and one that leads to the secretion of B cell recruitment factor(s).
在本报告中,我们通过T细胞增殖或T细胞依赖的B细胞刺激,研究了静止的小B细胞作为抗原呈递细胞(APC)对抗原特异性MHC限制性T细胞的作用能力。我们发现,14个体外抗原特异性MHC限制性T细胞克隆和系中的10个,以及4个T细胞杂交瘤中的3个,在存在轻度照射(1000拉德)的纯化B细胞和适当的外来抗原时,能够被诱导增殖或分泌白细胞介素-2。所有T细胞系和杂交瘤都能被富含巨噬细胞和树突状细胞的群体刺激而增殖或产生白细胞介素-2,并且除了一个杂交瘤外,所有测试的T细胞在用B细胞作为APC刺激时都会引起B细胞活化。此外,轻度照射的、高度纯化的同基因B细胞作为诱导B细胞活化的APC来源,其效力与低密度富含树突状细胞和巨噬细胞的细胞相同。还发现,从经抗原致敏的动物新鲜获取的淋巴结T细胞,在与纯化的B细胞和适当抗原一起培养时也会增殖。因此,静止的小B细胞可以作为多种T细胞的APC发挥作用。当细胞用1000拉德照射时,这种APC功能很容易检测到,但当用3300拉德照射时,其功能会大大减弱或消失。因此,其他一些实验室未能观察到这一现象,可能是由于B细胞抗原呈递功能的相对放射敏感性所致。此外,这种放射敏感性使我们能够很容易地将B细胞抗原呈递与树突状细胞和巨噬细胞的呈递区分开来,因为后者对3300拉德具有抗性。最后,一个在用B细胞作为APC时未能增殖的T细胞克隆,在同基因B细胞和适当抗原存在的情况下,能够促使同种异体B细胞增殖。这一结果表明,T细胞中至少存在两种不同的活化途径,一种导致T细胞增殖,另一种导致B细胞募集因子的分泌。